ALNY vs. THC: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALNY and THC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ALNY dominates in value with a market cap of 38.15 billion USD, eclipsing THC’s 15.12 billion USD by roughly 2.52×.
THC carries a higher beta at 1.63, indicating it’s more sensitive to market moves, while ALNY remains steadier at 0.17.
| Symbol | ALNY | THC |
|---|---|---|
| Company Name | Alnylam Pharmaceuticals, Inc. | Tenet Healthcare Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical - Care Facilities |
| CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. | Dr. Saumya Sutaria M.D. |
| Price | 292.58 USD | 162.83 USD |
| Market Cap | 38.15 billion USD | 15.12 billion USD |
| Beta | 0.17 | 1.63 |
| Exchange | NASDAQ | NYSE |
| IPO Date | June 1, 2004 | March 17, 1980 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALNY and THC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ALNY and THC based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- ALNY posts a negative P/E of -140.68, reflecting last year’s net loss, while THC at 10.55 signals healthy earnings.
- ALNY posts a negative forward PEG of -38.16, hinting at anticipated earnings decline, whereas THC at 0.48 has projections for stable or growing earnings.
- ALNY has a negative Price-to-Free Cash Flow ratio of -506.05, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, THC (P/FCF 10.64) indicates positive free cash flow generation.
| Symbol | ALNY | THC |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | -140.68 | 10.55 |
| Forward PEG Ratio (TTM) | -38.16 | 0.48 |
| Price-to-Sales Ratio (P/S, TTM) | 16.25 | 0.74 |
| Price-to-Book Ratio (P/B, TTM) | 328.68 | 3.67 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | -506.05 | 10.64 |
| EV-to-EBITDA (TTM) | -251.73 | 5.70 |
| EV-to-Sales (TTM) | 16.37 | 1.23 |
| EV-to-Free Cash Flow (TTM) | -509.80 | 17.79 |
Dividend Comparison
Neither ALNY nor THC currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALNY | THC |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALNY and THC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ALNY and THC both have debt-to-equity ratios above 3 (11.28 and 3.15), reflecting aggressive use of debt that can amplify gains but also increase vulnerability to rising rates.
- With negative EBIT (-0.79), ALNY cannot cover its interest payments. THC, with an interest coverage of 5.80, meets its interest obligations.
| Symbol | ALNY | THC |
|---|---|---|
| Current Ratio (TTM) | 3.04 | 1.78 |
| Quick Ratio (TTM) | 2.98 | 1.70 |
| Debt-to-Equity Ratio (TTM) | 11.28 | 3.15 |
| Debt-to-Assets Ratio (TTM) | 0.31 | 0.45 |
| Interest Coverage Ratio (TTM) | -0.79 | 5.80 |